Accuitive Medical Ventures — Full Portfolio
7 tracked investments · listed companies and verified rows first
CardioFocus develops Pulsed Field Ablation (PFA) technologies and systems for electrophysiologists to treat complex cardiac arrhythmias with precision and control.
BiotechHealthtechMedical DevicesMarlborough, US
Lauren Jennings(Executive Officer)Warren Clark(Executive Officer)Stephen Sagon(Executive Officer, Director)inAnjie Roldan(Executive Officer)inWarren R. Clark III(Executive Officer)Stephan S. Ogilvie(CEO)in
Co-investorsBioBritSaints CapitalSV Health InvestorsOxford Bioscience PartnersSV Life Sciences
Nevro develops spinal cord stimulation systems for pain management, offering the Senza Trial Stimulator with high-frequency therapy options and wireless capability for patient trials and treatment.
AI & Machine LearningDigital HealthHealthtechMedical DevicesRedwood City, US
Co-investorsBay City CapitalNew Enterprise Associates (NEA)Aberdare Ventures
HealthtechDuluth, US
Anthony V. Lando(Executive Officer, Director)inTodd Meyer(Executive Officer)inDilip Paithanker(Executive Officer)Robert Leslie(Executive Officer)Dilip Paithankar(Executive Officer)in
BoardRebecca B. Robertson(Director)
Co-investorsDomain AssociatesVersant Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




